A study comparing the effect of various schedules of the 7-valent licensed CRM197 - conjugated pneumococcal vaccine (Prevnar) on carriage of Streptococcus pneumoniae in infants and toddlers
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2012
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 12 Apr 2010 Results published in the Journal of Infectious Diseases.
- 29 Aug 2006 New trial record.